Bruker Corporation BRKR

NASDAQHealth TechnologyUnited States

$61.59+1.26 (+2.09%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 59.1361.94
52-week range: 32.3768.98

Financial health

– / 5

Analyst view · 14 firms

Hold6 buy · 7 hold · 1 sell

Avg. target $68.00 (+10.4%)

Prices may be delayed and are for informational purposes only - not investment advice.

Bruker Corporation BRKR

NASDAQHealth TechnologyUnited States

$61.59+1.26 (+2.09%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 59.1361.94
52-week range: 32.3768.98

Financial health

– / 5

Analyst view · 14 firms

Hold6 buy · 7 hold · 1 sell

Avg. target $68.00 (+10.4%)

Valuation from filings

Calculated from the tables below and the current price ($61.59) · LTM · 2026/9 · 2026-09-30

P/E: —EPS $-1.10
P/B: 4.07BV/share $15.12
P/S: 2.67Sales/share $23.04
Return on equity: -5.4%Net income / equity
Net margin: -3.5%Operating margin -2.0%
Free cash flow yield: 2.6%Free cash flow / market cap

Revenue and net income

Fiscal year · $ billions · net margin below

RevenueNet Income

Financial statements

$ millions · Under each value: change against a year earlier

Upgrade to MakklerPRO to see every row.Upgrade to MakklerPRO

Fiscal year	2021	2022	2023	2024	2025	LTM
Income Statement
Revenue	2,418	2,531+5%	2,965+17%	3,366+14%	3,437+2%	3,513
Cost of Revenue
Gross Profit
Operating expenses
Operating Income
EBITDA
Pre-tax income
Income tax (expense) / benefit
Net Income	277	297+7%	427+44%	113-74%	(9)turned to a loss	(123)
Earnings per share ($)
Margins
Gross margin
Operating margin
EBITDA margin
Net margin

Taken from the company's own 10-K and 10-Q filings via the SEC's XBRL data service. The "LTM" column is the last completed fiscal year plus the current year to date, minus the same period a year earlier. Lines a company tags with a non-standard label are left blank rather than filled with an approximation. Not investment advice.